Single B Cell Screening

Learn how direct antigen labeling improves single B cell antibody screening by reducing background, enabling precise binding readouts, and supporting multiplex assays.

Antibody discovery often begins with a highly diverse population of B cells, only a fraction of which may produce antibodies with the desired specificity or functional properties. Single-cell screening provides a way to examine these cells individually while maintaining a connection between an antibody phenotype and the cell that produced it.

The idea of single-cell technology​ is to examine B cells individually. Droplet microfluidics extends this principle by placing individual cells into extremely small reaction compartments that can be generated and analyzed at high throughput.

Discover how microfluidics is revolutionizing single B cell antibody screening with high-throughput precision. Explore applications, advantages, and Biointron’s platform.

Explore how Biointron’s AbDrop™ platform combines microfluidics, single B cell screening, and NGS to accelerate antibody discovery and therapeutic development.

AbDrop™ isolates diverse, high-affinity antibodies rapidly. Biointron shows how this platform transforms discovery with speed, scale, and precision.

Single B cell screening accelerates discovery. Biointron demonstrates how this technology identifies potent antibodies faster, guiding therapeutic development.